Saltar al contenido

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social did:plc:b4o27tf7dzv6yrxdoevn7qtz

Your leading source of international, cutting-edge research, review, and opinion in clinical #diabetes and #endocrinology. IF=36·3. 🌐 thelancet.com/journals/landia/home

En Bluesky desde el

Seguidores
1.866
Siguiendo
751
Posts
1.297
Días en rankings
0

Resumen

The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) es un usuario de Bluesky que se unió el 3 febrero 2025. Tiene 1.866 seguidores, sigue a 751 cuentas y ha publicado 1.297 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔬 Don’t miss this important session! Join Prof. Chantal Mathieu for a Lab Talk at #EASD2026. 📅 2 Oct |🕙10:15 - 10:45 CEST | 📍 Arena Hear about her #lab, her #research & how she leads her team. Make sure to join the conversation in the Arena! It's going to be a great one! #Diabetes #LabTalk

    Ver post
  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔴 Happening now at #EASD2026. Today's session draws on insights from a major Phase 3 efficacy trial: TRIUMPH-2 of retatrutide in people with obesity & T2D with: 🎤 John Wilding 🎤 Juan Pablo Frias 🎤 Elif Ekinci 🎤 Elisabeth Van Rossum Chaired by Arya M. Sharma 📍 Happening now in the Paris Hall

    Ver post
  • European Association for the Study of Diabetes@easdnews.bsky.social

    Early detection saves lives. EU Commissioner Olivér Várhelyi launched the “#KnowYourNumbers” campaign for the first-ever #EUScreeningWeek. @easdnews.bsky.social, @escardio.bsky.social,@easoobesity.bsky.social &@eudiabetesforum.bsky.social welcome the proposal. 👉 health.ec.europa.eu/know-your-nu...

    Ver post
  • NIHR ARC East Midlands@arc-em.bsky.social

    A new framework published today in @thelancetendo.bsky.social sets out 35 core outcomes for testing interventions to modify the progression of #type2diabetes. Researchers from @arc-em.bsky.social and @uniofleicester.bsky.social are part of the team behind it. 🔗 arc-em.nihr.ac.uk/news/type-2-...

    Ver post
  • Will Herrington@willkidney.bsky.social

    Almost all u need 2 know about the remarkable clinical effects of #SGLT2i on the kidney in a wide ranging IPD metaanalysis (covers effects by albuminuria, predicted eGFR dip and novel exploratory eGFR slope methods). Please do read it! @oxpop.bsky.social @martinlandray.bsky.social

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.